Form 424B3 - Prospectus [Rule 424(b)(3)]:
SEC Accession No. 0001193125-13-212488
Filing Date
2013-05-10
Accepted
2013-05-10 07:30:18
Documents
1

Document Format Files

Seq Description Document Type Size
1 PROSPECTUS SUPPLEMENT d537087d424b3.htm 424B3 22639
  Complete submission text file 0001193125-13-212488.txt   23783
Mailing Address ONE KENDALL SQUARE BUILDING 1400 EAST 4TH FLOOR CAMBRIDGE MA 02139
Business Address ONE KENDALL SQUARE BUILDING 1400 EAST 4TH FLOOR CAMBRIDGE MA 02139 617-863-5524
INVIVO THERAPEUTICS HOLDINGS CORP. (Filer) CIK: 0001292519 (see all company filings)

EIN.: 000000000 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 424B3 | Act: 33 | File No.: 333-171998 | Film No.: 13831074
SIC: 3841 Surgical & Medical Instruments & Apparatus